Physician profile
Patty Lee
NPI 1942266044
$6,407.52
in general payments reported to CMS, 2019-2025
13 companies · $588 in 2025
The $588 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $403 · 2020: $60.60 · 2021: $30.93 · 2022: $264 · 2023: $144 · 2024: $4,918 · 2025: $588.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,560 · Travel and Lodging: $1,902 · Food and Beverage: $1,188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,559.69 |
| Travel and Lodging | $1,901.66 |
| Food and Beverage | $1,188.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,512.24 | 2021-2024 | |
| Integra Lifesciences Corporation | $509.07 | 2019-2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Medtronic, INC. | $477.09 | 2022-2025 | Pteye Parathyroid Detection System, Propel |
| Acclarent, INC | $278.16 | 2019-2020 | |
| Regeneron Healthcare Solutions, INC. | $231.80 | 2022-2025 | Dupixent |
| Glaxosmithkline, LLC. | $110.01 | 2023 | Nucala |
| Angiodynamics, INC. | $71.53 | 2019 | |
| Stryker Corporation | $63.46 | 2025 | Audion Et Dilation System |
| Aerin Medical INC. | $47.33 | 2024 | |
| Genzyme Corporation | $43.55 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $24.92 | 2025 | Keytruda |
| Ethicon US, LLC | $24.67 | 2022 | |
| Kaleo, INC. | $13.69 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patty Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.